Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 8, 2012 - Issue 8: Special Focus: Cancer Commentary Series. Guest Editors: Michael G. Hanna and Alex Kudrin
Submit an article Journal homepage
1,154
Views
31
CrossRef citations to date
0
Altmetric
Research Paper

Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: Results of a randomized, open label, active-controlled trial in healthy adult volunteers in India

Mysore Kalappa Sudarshan Anti-Rabies Clinic and Rabies Epidemiology Unit; Department of Community Medicine; Kempegowda Institute of Medical Sciences; Bangalore, India
,
Doddabele Hanumanthaiah Ashwath Narayana Anti-Rabies Clinic and Rabies Epidemiology Unit; Department of Community Medicine; Kempegowda Institute of Medical Sciences; Bangalore, India
,
Shampur Narayan Madhusudana Department of Neurovirology; WHO Collaborating Center for Research and Reference on Rabies; National Institute of Mental Health and Neurosciences; Bangalore, IndiaCorrespondence[email protected]
,
Ramesh Holla Anti-Rabies Clinic and Rabies Epidemiology Unit; Department of Community Medicine; Kempegowda Institute of Medical Sciences; Bangalore, India
,
Belludi Yajaman Ashwin Department of Neurovirology; WHO Collaborating Center for Research and Reference on Rabies; National Institute of Mental Health and Neurosciences; Bangalore, India
,
Bilagumba Gangaboraiah Anti-Rabies Clinic and Rabies Epidemiology Unit; Department of Community Medicine; Kempegowda Institute of Medical Sciences; Bangalore, India
&
Haradanahalli S. Ravish Anti-Rabies Clinic and Rabies Epidemiology Unit; Department of Community Medicine; Kempegowda Institute of Medical Sciences; Bangalore, India
 show all
Pages 1077-1081 | Received 27 Jan 2012, Accepted 22 Apr 2012, Published online: 01 Aug 2012

References

  • WHO expert consultation on rabies. First report. WHO Technical Report series 931, Geneva, 2005. p. 3- 4.
  • Wilde H. Failures of post-exposure rabies prophylaxis. Vaccine 2007; 25:7605 - 9; http://dx.doi.org/10.1016/j.vaccine.2007.08.054; PMID: 17905484
  • Shantavasinkul P, Tantawichien T, Wilde H, Sawangvaree A, Kumchat A, Ruksaket N, et al. Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis 2010; 50:56 - 60; http://dx.doi.org/10.1086/649211; PMID: 19995217
  • World Health Organization. Human and dog rabies prevention and control, Report of the WHO/ Bill and Melinda Gates Foundation Consultation, Annecy, France, 2009. p. 20.
  • Bahmanyar M, Fayaz A, Nour-Salehi S, Mohammadi M, Koprowski H. Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA 1976; 236:2751 - 4; http://dx.doi.org/10.1001/jama.1976.03270250019017; PMID: 1036566
  • Centers for Disease Control and Prevention. Use of a reduced (4-dose) vaccine schedule for post exposure prophylaxis to prevent human rabies. Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2010; 59:RR-2 1 - 9
  • WHO expert committee on rabies. 8th report. Technical Report Series No. 824. Geneva: 1992. p. 10.
  • National Institute of communicable Diseases: National guidelines for rabies prophylaxis and intradermal administration of cell culture rabies vaccines, New Delhi, 2007. p. 14.
  • Mahendra BJ, Harish BR, Vinay M. A study of factors influencing compliance to IDRV at anti-rabies clinic of Mandya Institute of Medical Sciences, Mandya. APCRI Journal 2009; 11:18 - 20
  • Jesha M, Martin J, Bina T, Raphel L. Lailabi, Jayadev. Compliance to IDRV at the anti rabies clinic in atertiary care hospital in North Kerala. APCRI Journal 2011; 12:21 - 4
  • Thraenhart O, Marcus I, Scheiermann N. 3-1 scheme, a regimen of only two clinic visits with optimal antibody and interferon-induction. Progress in rabies control. Kent, England: Wells Medical; 1989. p. 536-47.
  • Khawplod P, Wilde H, Tepsumethanon S, Limusanno S, Tantawichien T, Chomchey P, et al. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin. Clin Infect Dis 2002; 35:1562 - 5; http://dx.doi.org/10.1086/344954; PMID: 12471579
  • Sampath G, Madhusudana SN, Sudarshan MK, Ashwathnarayana DH, Mahendra BJ, Ullas TP, et al. Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine. Vaccine 2010; 28:4086 - 90; http://dx.doi.org/10.1016/j.vaccine.2010.03.064; PMID: 20403351
  • Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000; 78:693 - 8; PMID: 10859864
  • Madhusudana SN, Sanjay TV, Mahendra BJ, Sudarshan MK, Narayana DH, Giri A, et al. Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML. Hum Vaccin 2006; 2:200 - 4; http://dx.doi.org/10.4161/hv.2.5.3197; PMID: 17035734
  • Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Vaccine 2006; 24:4116 - 21; http://dx.doi.org/10.1016/j.vaccine.2006.02.036; PMID: 16545510
  • Ashwathnarayana DH, Madhusudana SN, Sampath G, Satapathy DM, Mankeshwar R, Ravish HS, et al. A comparative study on the safety and immunogenicity of purified duck embryo cell rabies vaccine (PDEV, Vaxirab) with purified chick embryo cell rabies vaccine (PCECV, Rabipur) and purified vero cell rabies vaccine (PVRV, Verorab). Vaccine 2009; 28:148 - 51; http://dx.doi.org/10.1016/j.vaccine.2009.09.090; PMID: 19818720
  • Madhusudana SN, Anand NP, Shamsundar R. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals. Int J Infect Dis 2002; 6:210 - 4; http://dx.doi.org/10.1016/S1201-9712(02)90113-X; PMID: 12718837

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.